Concomitant medical products: product id: 8784, serial#: (b)(4), implanted: (b)(6) 2021, explanted: (b)(6) 2022, product type: catheter.
Product id: 8780, serial#: (b)(4), implanted: (b)(6) 2021, explanted: (b)(6) 2022, product type: catheter.
Other relevant device(s) are: product id: 8784, serial/lot #: (b)(4), ubd: 26-jan-2023, udi#: (b)(4); product id: 8780, serial/lot #: (b)(4), ubd: 05-feb-2023, udi#: (b)(4).
If information is provided in the future, a supplemental report will be issued.
|
Information was received from multiple sources (manufacturer representative, healthcare provider) regarding a patient who was receiving gablofen (500 mccg/ml at 100 mcg/day) via an implantable pump for intractable spasticity.
It was reported that the patient had been experiencing more and more spasticity since the initial implant.
There were no factors that may have led or contributed to the issue.
Logs were read and cap (catheter access port) aspiration was attempted on (b)(6) 2022 by managing healthcare provider staff.
Cap aspiration was unsuccessful.
The hcp was asked to revise the catheter on (b)(6) 2022.
Upon examination, the hcp noted no spontaneous flow from the catheter nor was the hcp able to aspirate the catheter through the cap intra-operation.
As the hcp worked from the pump back to the spinal incision making several cuts of the catheter to see if there was any flow.
Not until the hcp pulled the catheter back quite a bit was the hcp able to see some dripping of csf (cerebrospinal fluid).
The hcp decided at that point to replace the entire catheter as well as replace the pump even though there was no allegation of anything malfunctioning with the pump.
The issue was resolved at the time of report.
The patient's medical history was asked and will not be made available.
The patient's status at the time of report was alive - no injury.
|